Global Isoflurane Market Growth 2025-2031
Description
The global Isoflurane market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Isoflurane, sold under the trade name Forane among others, is a general anesthetic。It can be used to start or maintain anesthesia.[1] Often another medication is used to start anesthesia due to airway irritation with isoflurane.It is used by inhalation.Side effects include a decreased ability to breathe (respiratory depression), low blood pressure, and irregular heartbeat. Serious side effects may include malignant hyperthermia and high blood potassium.It should not be used in people with a history of malignant hyperthermia in either themselves or their family members.It is unknown if use during pregnancy is safe for the baby, but use during a cesarean section appears to be safe.Isoflurane is in the halogenated ether family of medication.Isoflurane was approved for medical use in the United States in 1979. It is on the World Health Organization"s List of Essential Medicines, the most effective and safe medicines needed in a health system.
United States market for Isoflurane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Isoflurane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Isoflurane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Isoflurane players cover Piramal Critical Care(Piramal Group), Halocarbon, Aesica(Consort Medical Group), Lunan Pharmaceutical Group, Shandong Keyuan Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Isoflurane Industry Forecast” looks at past sales and reviews total world Isoflurane sales in 2024, providing a comprehensive analysis by region and market sector of projected Isoflurane sales for 2025 through 2031. With Isoflurane sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Isoflurane industry.
This Insight Report provides a comprehensive analysis of the global Isoflurane landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Isoflurane portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Isoflurane market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Isoflurane and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Isoflurane.
This report presents a comprehensive overview, market shares, and growth opportunities of Isoflurane market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Human Series
Animal Series
Segmentation by Application:
Hospitals
Other Medical Institutions
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Piramal Critical Care(Piramal Group)
Halocarbon
Aesica(Consort Medical Group)
Lunan Pharmaceutical Group
Shandong Keyuan Pharmaceutical Co., Ltd.
Pfizer
Indofine Chemical Company, Inc.
Medicon Lifesciences
Rewine Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Isoflurane market?
What factors are driving Isoflurane market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Isoflurane market opportunities vary by end market size?
How does Isoflurane break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Isoflurane, sold under the trade name Forane among others, is a general anesthetic。It can be used to start or maintain anesthesia.[1] Often another medication is used to start anesthesia due to airway irritation with isoflurane.It is used by inhalation.Side effects include a decreased ability to breathe (respiratory depression), low blood pressure, and irregular heartbeat. Serious side effects may include malignant hyperthermia and high blood potassium.It should not be used in people with a history of malignant hyperthermia in either themselves or their family members.It is unknown if use during pregnancy is safe for the baby, but use during a cesarean section appears to be safe.Isoflurane is in the halogenated ether family of medication.Isoflurane was approved for medical use in the United States in 1979. It is on the World Health Organization"s List of Essential Medicines, the most effective and safe medicines needed in a health system.
United States market for Isoflurane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Isoflurane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Isoflurane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Isoflurane players cover Piramal Critical Care(Piramal Group), Halocarbon, Aesica(Consort Medical Group), Lunan Pharmaceutical Group, Shandong Keyuan Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Isoflurane Industry Forecast” looks at past sales and reviews total world Isoflurane sales in 2024, providing a comprehensive analysis by region and market sector of projected Isoflurane sales for 2025 through 2031. With Isoflurane sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Isoflurane industry.
This Insight Report provides a comprehensive analysis of the global Isoflurane landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Isoflurane portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Isoflurane market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Isoflurane and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Isoflurane.
This report presents a comprehensive overview, market shares, and growth opportunities of Isoflurane market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Human Series
Animal Series
Segmentation by Application:
Hospitals
Other Medical Institutions
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Piramal Critical Care(Piramal Group)
Halocarbon
Aesica(Consort Medical Group)
Lunan Pharmaceutical Group
Shandong Keyuan Pharmaceutical Co., Ltd.
Pfizer
Indofine Chemical Company, Inc.
Medicon Lifesciences
Rewine Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Isoflurane market?
What factors are driving Isoflurane market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Isoflurane market opportunities vary by end market size?
How does Isoflurane break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
103 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Isoflurane by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Isoflurane by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
